Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
IDF uncovers 7 km.-long Gaza terror tunnel where Hamas held Hadar Goldin - 2Find the Force of The ability to understand anyone on a deeper level: Improving Mindfulness and Connections
- 3Bitcoin momentum builds in Abu Dhabi as global interest surges
- 4Native Americans had dice and games of probability long before other cultures, study finds
- 5Europe pledges over €15bn for clean energy for Africa
- the Kinds of Thailand: Decision in favor of Your Number one Thai Dish!
- Find Your Internal Culinary expert: Cooking Strategies and Recipes
- 'Stranger Things' series finale trailer shows Hawkins gang gearing up for last battle with Vecna
- Toyota Just Electrified a Pickup Legend, but It Won’t Be Cheap
- Mountain Trekking on a Tight spending plan: Tracking down the Right Bicycle
- Spanish woman, 25, dies by legal euthanasia in case that drew national spotlight
- Step by step instructions to Contrast Lab Precious stones and Normal Jewels
- Former school bus aide pleads guilty to assaulting 3 autistic students in Colorado
- Viable Monetary Tips to Advance Your Monetary Circumstance
